eFFECTOR Therapeutics Inc’s recent filing unveils that its 10% Owner SR ONE CAPITAL MANAGEMENT, LLC unloaded Company’s shares for reported $0.37 million on Nov 27 ’23. In the deal valued at $0.61 per share,609,163 shares were sold. As a result of this transaction, SR ONE CAPITAL MANAGEMENT, LLC now holds 1,821,415 shares worth roughly $3.88 million.
Stifel downgraded its eFFECTOR Therapeutics Inc [EFTR] rating to a Hold from a a Buy in a research note published on January 25, 2022; the price target was decreased to $6.20 from $20. A number of analysts have revised their coverage, including Stifel’s analysts, who increased its forecast for the stock in early November from “a Hold” to “a Buy”. Credit Suisse began covering EFTR with “an Outperform” recommendation on October 12, 2021. Mizuho started covering the stock on October 04, 2021. It rated EFTR as “a Buy”.
Price Performance Review of EFTR
On Monday, eFFECTOR Therapeutics Inc [NASDAQ:EFTR] saw its stock fall -15.14% to $2.13. Over the last five days, the stock has lost -86.41%. eFFECTOR Therapeutics Inc shares have fallen nearly -81.77% since the year began. Nevertheless, the stocks have fallen -77.84% over the past one year. While a 52-week high of $37.00 was reached on 03/04/24, a 52-week low of $2.49 was recorded on 04/08/24. SMA at 50 days reached $11.85, while 200 days put it at $14.28. A total of 1.33 million shares were traded, compared to the trading of 0.25 million shares in the previous session.
Levels Of Support And Resistance For EFTR Stock
The 24-hour chart illustrates a support level at 2.01, which if violated will result in even more drops to 1.88. On the upside, there is a resistance level at 2.35. A further resistance level may holdings at 2.56. The Relative Strength Index (RSI) on the 14-day chart is 26.66, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.80%. Stochastics %K at 0.59% indicates the stock is a buying.
How much short interest is there in eFFECTOR Therapeutics Inc?
A steep rise in short interest was recorded in eFFECTOR Therapeutics Inc stocks on Mar 15, 2024, growing by 0.21 million shares to a total of 0.32 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.1 million shares. There was a rise of 67.31%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 10.47% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.65.
The most recent change occurred on September 21, 2021 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $33 price target.
